Senseonics (NYSE:SENS) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS) in a research note issued to investors on Sunday. The firm issued a sell rating on the stock.

Senseonics Stock Down 1.6 %

Shares of Senseonics stock traded down $0.01 during midday trading on Friday, hitting $0.38. The company’s stock had a trading volume of 2,024,873 shares, compared to its average volume of 2,165,094. The firm has a market capitalization of $203.75 million, a P/E ratio of -2.79 and a beta of 0.82. Senseonics has a 1-year low of $0.37 and a 1-year high of $0.86. The company has a quick ratio of 3.70, a current ratio of 3.96 and a debt-to-equity ratio of 1.79. The stock has a 50-day simple moving average of $0.42 and a 200-day simple moving average of $0.50.

Senseonics (NYSE:SENS) last announced its earnings results on Monday, May 13th. The company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03). Senseonics had a negative return on equity of 202.32% and a negative net margin of 346.38%. The business had revenue of $5.05 million for the quarter, compared to the consensus estimate of $4.76 million. As a group, sell-side analysts expect that Senseonics will post -0.12 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SENS. Virtu Financial LLC bought a new stake in shares of Senseonics during the 1st quarter valued at about $162,000. Price T Rowe Associates Inc. MD boosted its position in shares of Senseonics by 16.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after acquiring an additional 51,000 shares during the last quarter. Vanguard Group Inc. raised its stake in Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock valued at $11,963,000 after purchasing an additional 155,715 shares in the last quarter. State Board of Administration of Florida Retirement System purchased a new stake in shares of Senseonics in the first quarter valued at $91,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Senseonics by 30.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after acquiring an additional 211,128 shares during the period. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.